Clinical Trials in New York

Showing 11941-11960 of 22,668 trials

MarginProbe® System U.S. Post-Approval Study

NCT02406599

The study objective is to determine the MarginProbe® System's diagnostic accuracy at the margin level and impact on Positive Margin\* Presence originating from the Main ex-vivo lumpectomy specimen after the initial lumpectomy surgery. \*A positive margin is defined in this study as a margin microscopically measured and reported in the histology report to have cancer within 1 mm or less of the inked surface

Breast Cancer

Dune Medical Devices440 participantsStarted Jun 2015

Washington D.C., District of Columbia, United States • Jacksonville, Florida, United States • Tampa, Florida, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT01190449

RATIONALE: Monoclonal antibodies, such as ofatumumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. PURPOSE: This randomized phase II trial is studying ofatumumab to see how well it works in treating patients with previously untreated stage II, stage III, or stage IV follicular non-Hodgkin lymphoma.

Lymphoma

Alliance for Clinical Trials in Oncology51 participantsStarted Aug 2011

Lewes, Delaware, United States • Newark, Delaware, United States • Weston, Florida, United States +45 more locations

MarginProbe® System U.S. Post-Approval Study

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Find Trials by Condition in New York

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Capnometry-Assisted Breathing Training for COPD

Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

The Healthy Life Choices Project in HIV-Positive Patients

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness

A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma

Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

Study of Octanorm Subcutaneous IG in Patients With PID